Kazuto Oya

Estimated cognitive decline in patients with schizophrenia: A multicenter study

Haruo Fujino, Chika Sumiyoshi, Yuka Yasuda et al. · Psychiatry and Clinical Neurosciences · 2016 · 69 citations

Medicine, Psychiatry, Psychology +17

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population

Taro Kishi, Toshikazu Ikuta, Shinji Matsunaga et al. · Neuropsychiatric Disease and Treatment · 2017 · 27 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Suvorexant for insomnia in patients with psychiatric disorder: A 1‐week, open‐label study

Taro Kishi, Kenji Sakuma, Makoto Okuya et al. · Neuropsychopharmacology Reports · 2019 · 17 citations · Full text

Medicine, Pharmacology, Psychiatry +14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Taro Kishi, Kazuto Oya, Yuki Matsui et al. · Neuropsychiatric Disease and Treatment · 2018 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms

Hiroyoshi Takeuchi, Yoshiteru Takekita, Hikaru Hori et al. · Human Psychopharmacology Clinical and Experimental · 2021 · 13 citations · Full text

Medicine, Pharmacology, Psychiatry +17